Search Results

There are 21671 results for: content related to: Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells

  1. You have free access to this content
    miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells


    Volume 27, Issue 8, August 2009, Pages: 1712–1721, Dejuan Kong, Yiwei Li, Zhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, Hyeong-Reh Choi Kim and Fazlul H. Sarkar

    Version of Record online : 23 APR 2009, DOI: 10.1002/stem.101

  2. You have full text access to this Open Access content
    Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model

    Cancer Science

    Volume 102, Issue 4, April 2011, Pages: 769–775, Iori Sakai, Hideaki Miyake, Tomoaki Terakawa and Masato Fujisawa

    Version of Record online : 11 FEB 2011, DOI: 10.1111/j.1349-7006.2011.01854.x

  3. Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

    Journal of Cellular Biochemistry

    Volume 108, Issue 1, 1 September 2009, Pages: 272–284, B. Desai, T. Ma, J. Zhu and M.A. Chellaiah

    Version of Record online : 6 JUL 2009, DOI: 10.1002/jcb.22248

  4. You have free access to this content
    Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model

    BJU International

    Volume 106, Issue 1, July 2010, Pages: 121–127, Masafumi Kumano, Hideaki Miyake, Tomoaki Terakawa, Junya Furukawa and Masato Fujisawa

    Version of Record online : 12 NOV 2009, DOI: 10.1111/j.1464-410X.2009.09047.x

  5. You have free access to this content
    Functional evidence implicating S100P in prostate cancer progression

    International Journal of Cancer

    Volume 123, Issue 2, 15 July 2008, Pages: 330–339, Gargi D. Basu, David O. Azorsa, Jeffrey A. Kiefer, Angela M. Rojas, Sukru Tuzmen, Michael T. Barrett, Jeffrey M. Trent, Olli Kallioniemi and Spyro Mousses

    Version of Record online : 1 MAY 2008, DOI: 10.1002/ijc.23447

  6. You have full text access to this OnlineOpen article
    Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness

    FEBS Open Bio

    Volume 4, Issue 1, January 01, 2014, Pages: 627–636, M. Moazzem Hossain, Xin Wang, Raymond C. Bergan and J.-P. Jin

    Version of Record online : 24 JUN 2014, DOI: 10.1016/j.fob.2014.06.003

  7. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer

    The Prostate

    Volume 75, Issue 9, June 15, 2015, Pages: 923–935, Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia and Sílvia Socorro

    Version of Record online : 18 MAR 2015, DOI: 10.1002/pros.22976

  8. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity

    Journal of Cellular Biochemistry

    Volume 114, Issue 5, May 2013, Pages: 1135–1144, Cinzia Borghese, Lara Cattaruzza, Eliana Pivetta, Nicola Normanno, Antonella De Luca, Mario Mazzucato, Marta Celegato, Alfonso Colombatti and Donatella Aldinucci

    Version of Record online : 14 MAR 2013, DOI: 10.1002/jcb.24456

  9. You have free access to this content
    H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis

    International Journal of Cancer

    Volume 118, Issue 1, 1 January 2006, Pages: 62–73, Josh D. Silvertown, Jonathan Ng, Takeya Sato, Alastair J. Summerlee and Jeffrey A. Medin

    Version of Record online : 27 JUL 2005, DOI: 10.1002/ijc.21288

  10. Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

    Journal of Cellular Biochemistry

    Volume 104, Issue 4, 1 July 2008, Pages: 1452–1464, N.A. Cross, E.A. Waterman, N. Jokonya, A. Fowles, C.H. Buckle, J. Phillips, I. Holen, F.C. Hamdy and C.L. Eaton

    Version of Record online : 4 MAR 2008, DOI: 10.1002/jcb.21721

  11. The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFβ in prostate cancer cells

    Journal of Cellular Biochemistry

    Volume 109, Issue 4, 1 March 2010, Pages: 828–837, Margaretha van der Deen, Jacqueline Akech, Tao Wang, Thomas J. FitzGerald, Dario C. Altieri, Lucia R. Languino, Jane B. Lian, Andre J. van Wijnen, Janet L. Stein and Gary S. Stein

    Version of Record online : 15 JAN 2010, DOI: 10.1002/jcb.22463

  12. You have free access to this content
    Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

    International Journal of Cancer

    Volume 125, Issue 9, 1 November 2009, Pages: 2004–2013, Monica Marra, Daniele Santini, Giuseppina Meo, Bruno Vincenzi, Silvia Zappavigna, Alfonso Baldi, Maciej Rosolowski, Giuseppe Tonini, Markus Loeffler, Ruth Lupu, Santolo Rosario Addeo, Alberto Abbruzzese, Alfredo Budillon and Michele Caraglia

    Version of Record online : 15 JUN 2009, DOI: 10.1002/ijc.24648

  13. You have full text access to this Open Access content
    Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis

    Cancer Science

    Volume 99, Issue 12, December 2008, Pages: 2373–2379, Naoyuki Satoh, Yoshihiro Yamada, Yumi Kinugasa and Nobuyuki Takakura

    Version of Record online : 19 NOV 2008, DOI: 10.1111/j.1349-7006.2008.00961.x

  14. IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation

    Journal of Cellular Biochemistry

    Volume 113, Issue 5, May 2012, Pages: 1569–1580, Hernan Roca, Matthew J. Craig, Chi Ying, Zachary S. Varsos, Paul Czarnieski, Ajjai S. Alva, James Hernandez, David Fuller, Stephanie Daignault, Patrick N. Healy and Kenneth J. Pienta

    Version of Record online : 15 MAR 2012, DOI: 10.1002/jcb.24025

  15. You have free access to this content
    Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells

    International Journal of Cancer

    Volume 118, Issue 4, 15 February 2006, Pages: 1022–1031, Murielle Mimeault, Erik Moore, Nicolas Moniaux, Jean-Pierre Hénichart, Patrick Depreux, Ming-Fong Lin and Surinder K. Batra

    Version of Record online : 17 AUG 2005, DOI: 10.1002/ijc.21440

  16. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

    The Prostate

    Volume 70, Issue 14, 1 October 2010, Pages: 1501–1512, Keitaro Kojima, Yasunori Fujita, Yoshinori Nozawa, Takashi Deguchi and Masafumi Ito

    Version of Record online : 1 JUN 2010, DOI: 10.1002/pros.21185

  17. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells

    The Prostate

    Volume 75, Issue 10, July 1, 2015, Pages: 1020–1033, Sumeet Jain, Sujit Suklabaidya, Biswajit Das, Sunil K. Raghav, Surinder K. Batra and Shantibhusan Senapati

    Version of Record online : 2 APR 2015, DOI: 10.1002/pros.22983

  18. You have free access to this content
    Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner

    International Journal of Cancer

    Volume 122, Issue 11, 1 June 2008, Pages: 2482–2490, Sanaa M. Nabha, Emanuel Burck dos Santos, Hamilto A. Yamamoto, Abdelfettah Belizi, Zhong Dong, Hong Meng, Allen Saliganan, Aaron Sabbota, R. Daniel Bonfil and Michael L. Cher

    Version of Record online : 6 MAR 2008, DOI: 10.1002/ijc.23431

  19. Cancer-Cell-Phenotype-Dependent Differential Intracellular Trafficking of Unconjugated Quantum Dots


    Volume 5, Issue 3, February 6, 2009, Pages: 370–376, Sutapa Barua and Kaushal Rege

    Version of Record online : 16 DEC 2008, DOI: 10.1002/smll.200800972

  20. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 856–867, J.Y. Henry, L. Lu, M. Adams, B. Meyer, J.B. Bartlett, Prof. A.G. Dalgleish and C. Galustian

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pros.21488